IDEAYA Biosciences (IDYA) Stock Highlights

25.61 | +3.31%

2024-12-21 03:11:34

IDEAYA Biosciences Inc an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The companys product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.

Statistics

Range Today

24.51 26.49

Volume Today 2.02M

Range 1 Year

24.48 47.74

Volume 1 Year 216.8M

Range 3 Year

8.14 47.74

Volume 3 Year 474.54M

Range 10 Year

2.95 47.74

Volume 10 Year 588.33M

Highlights

Market Capitalization 2.7B (mid)

Floating Shares 85.54M

Current Price 25.61

Price To Earnings -12.81

Price To Revenue 431.12

Price To Book 2.29

Earnings Per Share -2.33

Payout Ratio 0%

Performance

Latest +3.31%

1 Month -0.23%

3 Months -27.18%

6 Months -31.3%

1 Year -25.9%

3 Years +20.12%

5 Years +212.7%

10 Years +82.93%

Benchmarks

Market Capitalization

53 / 368

Gross Profits

187 / 278

Total Revenue

154 / 300

Total Rank

147 / 368

Free Cashflow

252 / 352

Performance 5 years

36 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.